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Introduction
Although migraine has been known since the time of the
Ancient Greeks (the term being derived from hemi-crania
– the Greek for one-sided headache), our knowledge of
its causes and treatment is much more recent. The main
cause for its long neglect was the failure to consider it a
serious disorder, because “everyone has headaches”.
Even neurologists, specialists in disorders of the nervous
system, gave it scant attention because of their need to
deal with more serious, even fatal, conditions; this was in
spite of the fact that a quarter of all patients attending
neurological out-patient departments are there because of
headache. The neglect by the medical profession was
such that as a student, both undergraduate and postgradu-
ate, including neurological training, I did not receive one
single lecture on headache.
Patients were naturally dissatisfied, so it was not sur-
prising when one such sufferer, Peter Wilson, whose
migraine started at the age of 12 and continued to his sev-
enth decade, contacted others with the same complaint. In
March 1958, encouraged by a pharmacist, George Ball,
Peter advertised a meeting for those with migraine in a
local newspaper, the Bournemouth Evening Echo. The
meeting was held in the flat of one of the ten people
attending; each contributed £10 so that a group was start-
ed with Peter Wilson, a local government officer, as its
Honorary Secretary1. With an announcement of its forma-
tion in a national daily paper – the Daily Telegraph –
another 200 people became involved, including a Nobel
Prize winner, well known writers, scientists and several
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doctors. By the end of the following year, there were over
1000 members. In 1964 this group of patients formed the
British Migraine Association; its purpose was “to encour-
age the creation of headache clinics and to raise money for
headache research” [1]2.
Although the British Migraine Association was essen-
tially a patients’ organisation, set up as a charitable trust,
the need for more medical input was required and Dr
Macdonald Critchley was asked to help form the Migraine
Trust, and be the founding Chairman. One of its most
important functions was to organise meetings where clin-
ical scientists could regularly review what was known
about this complex disorder, stimulate research and report
their results.
In the mid-1960s, the British Migraine Association, led
by Peter Wilson, approached the Wellcome Foundation for
support. Doctor Richard Smith was then working there on
pain research and, in association with the College of
General Practitioners (before it became Royal), organised
a meeting for GPs on migraine, chaired by Macdonald
Critchley. Discussions between Critchley and Smith
reached the conclusion that “an organisation of sufficient
weight” was needed to “gain the attention and support of
the medico-scientific establishment” [2]. Smith
approached Lord Brain, the neurologist who was then
President of the Royal College of Physicians who agreed
to lead the effort to create a Migraine Trust. The first
Trustees besides Lord Brain were Lord and Lady Snow, Sir
Cyril Musgrove (a city financier) and Doctor Macdonald
Critchley, with Richard Smith as Secretary. Lady Snow
(the novelist Pamela Hansford Johnson) acted as liaison
between the Trust and the British Migraine Association.
Lord Brain asked HRH Princess Margaret to become the
Patron of the Trust, which she graciously accepted.
A fundraising dinner was held at Apothecaries Hall for
the first symposium on Background to Migraine. Lord
Brain passed away at this time and Lord Snow succeeded
him as Chairman. At that meeting Sir George Godber,
when Chief Medical Officer of the National Health
Service, had been criticised because of the absence of spe-
cial provision for migraine. He asked Critchley for help
and this is how the first two hospital migraine clinics
began. “For that” Sir George added, “I have always been
profoundly grateful to him.”
Background to migraine
The first Migraine Symposium was held in November
1965 at the National Hospital and its proceedings pub-
lished under the title of Background to Migraine [3]. It
was at this meeting that the first Sandoz Foundation
Lecture was given by Macdonald Critchley on “Migraine:
from Cappadocia to Queen Square” (Table 1). In his intro-
ductory speech, the then Minister of Health, the Right
Honourable Kenneth Robinson, quoted Ralph Waldo
Emerson, “at every stage we lose a foe; at fifty we lose our
sick headaches”, which indicated the truth that most forms
of headache lessen with age. He then wondered “what the
Cappadocians were doing at this gathering”, presumably
because he did not know that Aretaeus of Cappadocia was
the first to characterise migraine [4].
The interest engendered by this meeting led to a fur-
ther symposium in the following year with another publi-
cation [5]. On this occasion the second Sandoz
Foundation Lecture was given by Sir Derrick Dunlop
(Scotland) on The therapeutics of migraine, which fea-
tured ergotamine as the medication for the treatment of
acute attacks and methysergide for prevention.
The third Migraine Symposium had as its Sandoz
Foundation Lecturer Arnold Friedman (USA) whose
title was The (infinite) varieties of migraine [6]. These
proceedings included three chapters on dietary migraine
and tyramine, which proved to be a false trail, but
another topic, which proved highly rewarding, was by
Professor James Lance of Sydney on serotonin, as it
eventually resulted in the triptans being the best treat-
ment for acute attacks.
The fourth Migraine Symposium Sandoz lecture was
given by Professor John Cumings on Migraine – a bio-
chemical disorder? This volume [7] was aimed at general
Table 1 Sandoz Foundation Lectures
1966 Macdonald Critchley
Migraine: from Cappadocia to Queen Square
1967 Sir Derrick Dunlop
The therapeutics of migraine
1969 Arnold P. Friedman
The (infinite) variety of migraine
1970 John N. Cumings
Migraine, a biochemical disorder
1976 John Marshall
Cerebral flood flow in migraine
1978 James W. Lance
Migraine: an attempted synthesis
1980 Donald J. Dalessio
Recent experimental studies on headache
1982 Edwin Bickerstaff
Complicated migraine
1984 Maurice H. Lessof
Migraine: how much is due to allergy?
1986 Michael Moskowitz
Sensory connections to cephalic blood vessels and their 
possible importance to vascular headaches
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practitioners and had a chapter by Dr Marcia Wilkinson on
Migraine as seen in the London City Clinic. All these four
books of the proceedings were entitled Background to
Migraine, and published by Heinemann, with which Dr
Raymond Greene had a close connection3. The fifth
(1972) and sixth (1974) biennial migraine symposia had
only abstracts and were not published.
Headache clinics
In the UK, headache clinics had been started by Dr
Macdonald Critchley at both the London hospitals where
he worked, namely King’s College Hospital and the
National Hospital, Queen Square.
It was in the late 1960s that I was approached by a
pharmaceutical company, Sandoz, to undertake a clinical
trial on their new migraine preventative drug, known then
only as CB105. Having been appointed in 1965 as
Consultant Neurologist to the Charing Cross Group of
Hospitals, I began a weekly migraine clinic at one of the
constituent hospitals in Hammersmith – the West London
Hospital. A clinical assistant, Felicity Hartridge, funded
by Sandoz, was chosen to help4. The trial of CB105 as a
migraine prophylactic proved successful and it was mar-
keted by the company as Sanomigran (with the generic
name of pizotifen). It proved to have side effects of som-
nolence and weight increase, which were particularly
unwelcome in migraine patients, who tended to be
younger women.
Directors of the Migraine Trust
Derek Mullis, who served as Director of the Migraine
Trust during its most significant period of growth, began
his connection with the trust in 1965. After reading of its
founding, he wrote to the then Director offering to raise
money, because both his wife and daughter had migraine.
Invited to become a member of the Management
Committee, he soon became its Chairman, and later joined
the Medical Advisory Committee as its one “non-medic”
(personal communication). Appreciating that none of the
doctors who had consulted his wife for migraine had actu-
ally ever seen a patient in an acute attack, he mentioned
this at a Medical Advisory Committee and it transpired
that 12 out of 16 present were in favour of a clinic for the
treatment of acute attacks. Since Mullis had been a Lloyds
Underwriter and was familiar with the City of London, he
suggested the first clinic should be there because up to a
million people worked in the City during the day and
those having an acute attack would be able to be treated in
a darkened room, where they would lie down and be treat-
ed until recovered.
The first City migraine clinic
A public meeting was held under the chairmanship of
Lord (C.P.) Snow, with Sir Barnes Wallis as the main
speaker. St Bartholomew’s Hospital (Barts) was willing to
have the clinic under its auspices as long as there was no
financial requirement; through their Special Trustees, the
Migraine Trust was given a lease of “two completely bro-
ken-down shops in Little Britain”. It was opened in 1970
by the Royal Patron of the Trust, Princess Margaret,
Countess of Snowden with Dr Marcia Wilkinson as its
part-time Director.
The second migraine clinic
The clinic was an immediate success and had to move to
larger premises at 22 Charterhouse Square, which was
actually the first house outside the City of London. The
official opening took place on 17 May 1973 in Iron-
mongers Hall (where Derek Mullis was a member). Sir
Keith Joseph gave the note of thanks; Sir Ronald Bodley-
Scott, the Royal Physician, was then Chairman of the
Trustees.
Well known personalities became associated with the
Trust because they suffered from migraine, e.g., Sir Cyril
Kleinwort, who became the Honorary Treasurer and gave
the Trust £10 000 each year until he died; other sufferers
were the Marquis of Linlithgow, who became a Trustee, as
did Judge Argyle (who later preceded me as Chairman).
Lord (C.P.) Snow, whose wife had migraine, was succeed-
ed by Sir Thomas Holmes Sellors, a famous thoracic sur-
geon but without a specific interest in migraine.
In 1972, Mullis as Director and Critchley as Chairman
invited me to form another clinic for patients with acute
migraine attacks in the West London region. They offered
a house similar to the one in Charterhouse Square near
Charing Cross Hospital, but I pointed out that, as the New
Charing Cross Hospital was being opened, there was
ample accommodation available in the hospital. The
Hammersmith Area Health Authority accepted “responsi-
bility for the increased number of patients with migraine
who would be attending”. The only cost to the Migraine
Trust was in providing a Research Registrar. The Lease of
22 Charterhouse Square was for six years and in 1979
(with His Honour Judge Argyle, QC, as Chairman of
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Trustees) it was realised that an unacceptable proportion of
the Trust’s income was “being spent not on research but on
patient care which should be the responsibility of the
National Health Service”. The Trust ceased funding the
clinic in the City (which has since been supported by the
British Migraine Association and other private funding),
and the name of the Princess Margaret Migraine Clinic was
transferred to the one at the new Charing Cross Hospital.
In the 1980s research workers at the Princess Margaret
Migraine Clinic were awarded the Harold Wolff Award of
the American Association for the Study of Headache
(AASH) on two occasions for the best scientific presenta-
tion of that year. In 1984 the Harold Wolff Award was
given at the 26th Annual Meeting of the AASH, held in
San Francisco; the paper was on “Metabolic abnormalities
in cluster headaches”. As Founding Director of the
Princess Margaret Migraine Clinic, I was given the
Distinguished Clinician Award of AASH in 1986 at its
28th Annual Meeting, held in Chicago.
I became a trustee of the Migraine Trust in the early
1980s and succeeded to the Chairmanship, in which office
I remained for 10 years. As Chairman I helped organise
the biennial Migraine Trust International Symposia and
edited their proceedings5.
The Migraine Trust International Symposium (MTIS)
The first designated Migraine Trust International
Symposium was held in September 1976 and its proceed-
ings were entitled Current Concepts in Migraine [8].
The second MTIS in 1978 was not published, but the
third, held in 1980, was published the following year [9].
The first section, consisting of three chapters, was on clin-
ical aspects and included the effect of weather (Per-Olaf
Lundberg, Sweden) and cyclical migraine (Seymour
Diamond, USA). The Sandoz lecturer was Professor
Burnstock, who hypothesised that the underlying mecha-
nisms for migraine were in the nervous control of blood
vessels. Edda Hanington postulated a platelet disorder as
a cause of migraine. There was a whole section of six
chapters on platelet function but the research eventually
turned out to be unrewarding. Another new section was on
neurotransmitters (chemical messengers), which are still
being actively and rewardingly investigated.
The fourth MTIS [10], held in 1982, included a new
special lecture named for Professor J.N. Cumings, a past
Chairman of the Migraine Trust, and was given by
Professor Murray Harper (Scotland) on the blood-brain
barrier (Table 2). This named lecture was in addition to
the Sandoz Foundation Lecture which, on this occasion,
was given by Edwin Bickerstaff on “Complicated
migraine” dealing with the permanent complications pro-
duced by migraine. A reflection of the current research
interest was that Neurochemical Aspects included a dozen
chapters. The Symposium was held at Charing Cross
Hospital and the number of migraine specialists attending
had grown to 250 from 30 different countries. Derek
Mullis had by then retired as Director of the Migraine
Trust and was followed by Commander Oliver Wright.
The fifth MTIS was held in 1984, again at Charing
Cross Hospital. In his foreword to the proceedings [11],
Macdonald Critchley quoted Doctor Samuel Johnson “to a
man whose pleasure is intellectual, London is the place,
when a man is tired of London, he is tired of life, for there
is in London, all that life can afford… the full tide of exis-
tence is at Charing Cross”. At this gathering there were
300 specialists, again from 30 countries. The Cumings
Memorial Lecture was given by Professor Jes Olesen
(Denmark), on Vascular aspects of migraine pathophysi-
ology. Because of the current interest there was an addi-
tional section of five chapters on non-drug therapy.
Immediately following the fifth MTIS a series of lec-
tures were held on The management of migraine [12].
Intended for general physicians and family practitioners, it
presented the considerable increase in knowledge of the
many different causes of headaches. Supported by the
British Migraine Association and Sandoz Pharmaceuticals,
it was intended to help those doctors in primary care who
treated one of the most common complaints of mankind.
The biennial International Symposia of the Migraine
Trust were not sufficient to satisfy the need for
researchers to report their findings. For this reason, the
World Federation of Neurology (WFN), at its quadrennial
congress held in Kyoto, Japan in 1981, sponsored a sym-
posium under the auspices of the WFN Research Group in
Headache and Migraine. The proceedings [13] included
seven chapters of research findings emanating from the
Princess Margaret Migraine Clinic and funded by the
Migraine Trust.
Table 2 Cumings Memorial Lectures
1976 Merton Sandler
Monoamines and migraine – fact or fiction?
1978 John R. Vane
Prostacyclin and vascular tone
1982 A. Murray Harper
Possible role of monoamines, the blood–brain barrier and 
ATP in the pathogenesis of migraine
1984 Jes Olesen
Vascular aspects of migraine pathophysiology
1986 Aristides Leão
On the inferred relationship of migraine and spreading 
depression
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The sixth MTIS held in 1986 had broken new ground,
as it had to be expanded from two to three days and the
number of participants had increased to over 500, partly
due to satellite meetings of the International Headache
Society and the WFN Research Group on Headache and
Migraine. The last section of the volume [14] consisted of
8 chapters on chronic headache. The Cumings Memorial
Lecture was given by Professor Leão (Brazil), the
Brazilian neuroscientist who theorised spreading depres-
sion was the cause of the migrainous aura. The other
named lecture was by Professor Moskowitz (USA) on the
trigemino-vascular cause of migraine, where the sensory
nerves of the face also supplied blood vessels to the head.
The seventh MTIS was in September 1988 in London
and, although it lasted over three days, only a minority of
the submitted papers could be given as platform presenta-
tions, so that the proceedings ran to over 50 chapters [15].
This book recorded the tremendous increase over the pre-
vious two years of knowledge regarding headache and
migraine, particularly in neuro-imaging and fresh under-
standing of chemical messengers (neurotransmitters).
Divided into six sections, the first again dealt with clini-
cal aspects, such as the cause of pain in the head and the
mechanisms involved in migraine. One of the most impor-
tant chapters was the International Headache Society’s
Classification of Headache, which listed over 100 causes
of headache on a firmer basis by indicating the precise cri-
teria for diagnosis. This classification, produced by a
committee of 12, proved very useful by giving a standard-
ised basis for clinical trials (where one specific type of
headache could be used to compare different treatments).
It also proved useful in studying the genetic approach to
migraine6. The second, third and fourth sections dealt,
respectively, as was usual, with biochemical, vascular and
physiological (functional) aspects, but the fifth covered
cluster headache, a condition quite distinct from migraine,
because it affects mainly the male sex and begins at a later
age than migraine. The attacks last less than a few hours
but can be repeated daily for several weeks – hence the
term “cluster” headache. The pain is extremely severe
and, as the treatment is different from migraine, patients
should be seen by headache specialists. The final sixth
section on treatment concerned diet, hormones, feverfew,
depression and the dangers of too may painkillers.
The eighth MTIS, held in September 1990, was on the
occasion of the Silver Jubilee of the Trust. It was the
largest meeting of headache researchers ever held, with
over 1000 participants. The proceedings [16] consisted of
78 chapters divided into 10 sections. The section on clus-
ter headaches now consisted of 12 chapters with an analy-
sis of different groups, e.g., in different countries and in
children (epidemiology). The treatment sessions were
divided into prevention (prophylaxis), consisting of 12
chapters, and therapy of the acute attacks (8 chapters) as
well as dietary aspects (5 chapters).
In 1992 the ninth MTIS was held at Kensington Town
Hall, London and the resulting publication [17], in addi-
tion to the usual sections, had expanded on epidemiology
(different population groups) and genetics (with four
chapters). The Migraine Trust lecture was given on Recent
advances in cluster headache research by Dr Lee Kudrow
(USA). With the introduction of the triptans in 1991, there
was increased support from the pharmaceutical industry 
As 1995 was the 30th anniversary of the foundation of
the Migraine Trust, a special symposium was held at
Leeds Castle, where 24 of the most active international
researchers in migraine were invited; the proceedings
were published under the rubric of Towards Migraine
2000 [18]7. This four-day conference, in what has been
called the most beautiful castle in the United Kingdom,
was rewarding in that discussions on controversial topics
between the experts continued even during refreshment
breaks. It is to reflect these divergent opinions that some
of the discussions were included in the publication. It was
a great pleasure and honour to have the Patron of the
Migraine Trust, Her Royal Highness Princess Margaret as
Guest of Honour at the Symposium Dinner.
In considering book chapters based on work at the
Princess Margaret Migraine Clinic, Charing Cross Hospital,
worthy of mention are three contributions in the volume on
headache of the huge multivolume reference encyclopaedia
called Handbook of Clinical Neurology [19]. These three
chapters were on classification (Rose), drug therapy
(Peatfield) and trigeminal neuralgia (Illingworth).
The need for the Migraine Trust to inform patients and
relatives in simple everyday terms about causes and treat-
ments was soon apparent. This was evidenced by the num-
ber of calls to its Helpline and the number of questioning
letters received. Lay persons had a differing emphasis,
e.g., how to manage migraine without taking drugs. After
careful consideration articles on complementary tech-
niques, e.g., acupuncture, were included in the Migraine
Trust Newsletter. These articles were criticised by two
members of the Medical Advisory Committee on the
grounds that they had not been scientifically proven to be
efficacious by controlled clinical trials. (Indeed, one
member of that committee – a Nobel Prize winner –
resigned on this issue.)
It was the need to inform patients that induced the
Oxford University Press to publish a book for sufferers.
The Migraine Trust’s Research Registrar, Doctor Marek
Gawel, and I were asked to undertake this task [20]; it is
available both in hardback and softback covers. A second
edition, much revised, was brought out by another pub-
lisher nearly a quarter of a century later [21], which
attempted to include the striking advances in layman’s
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terms. The only changes in chapter headings was an addi-
tional chapter on Post-traumatic headaches (headaches
after a head injury) and instead of a chapter entitled “The
future”, some realisation had occurred and the chapter was
now “Headache clinics and the future”.
Another registrar attending the Princess Margaret
Migraine Clinic (Dr Paul Davies) was instrumental in a
book for lay persons entitled Answers to Migraine [22]. This
was published between editions of Migraine, The Facts.
The relationship between clinical trials, researchers and
the pharmaceutical companies supporting these endeav-
ours has been much discussed. Obviously the Migraine
Trust, in organising symposia, had to draw a clear line
between the reported results and the support they obtained
in the publications with which the Trust was associated.
An example of this was a Symposium held in 1981
(between the two Migraine Trust International Symposia of
1980 and 1982) at the University of Sussex. At that time the
question of lack of oxygen to the brain as a cause of
migraine was being investigated. The meeting was under
the auspices of Janssen Research Foundation (funded by
the Janssen Pharmaceutical Company of Belgium) and the
Migraine Trust and their new product of flunarizine was
postulated as a preventive remedy for migraine; following
several scientific sections of this particular mechanism, I
reported on a trial done at the Princess Margaret Migraine
Clinic using flunarizine as a preventive of migraine attacks,
and my conclusion was that “further studies are required to
confirm the drug’s efficiency”. Although flunarizine was
much used on the Continent in migraine prevention, it was
not often prescribed for this purpose in the UK [10, 23].
Conclusion
The frequency of publications and the numbers of papers
offered at each Migraine Trust International Symposium
is indicative of the rapid progress made in headache sci-
ence in those years.
Notes
1. Although he was later offered the post of the first Director of the
Migraine Trust, he declined because it would have meant a move
to London. Peter Wilson’s dedicated work was recognised official-
ly in 1967 by the award of Member of the British Empire (MBE).
2. The membership now numbers several thousands. In 1997 its
name was changed to the Migraine Action Association.
3. He was the brother of the author Graham, a migraine sufferer,
and a Trustee.
4. The daughter of Professor Hamilton Hartridge, the famous phys-
iologist, she was a graduate of King’s College Hospital and rec-
ommended by Macdonald Critchley.
5. In the 1970s Macdonald Critchley asked me to join the Research
Group on Headache and Migraine of the World Federation of
Neurology, later to be its Secretary and finally to succeed
Macdonald Critchley as its Chairman. The Research Group was
limited to 30 international experts and met at the quadrennial meet-
ings of the World Congress of Neurology.
6. Being one of the 12 doctors responsible for The International
Headache Society Classification of Headache and Migraine, I was
made a life member of the International Headache Society (IHS).
7. This brought the number of books on migraine and headache
with my name on the spine to 16, a measure of how often it was
necessary to record the rapidly developing research in the disorder.
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